china national biotec group company limited
Riboxx Pharma, China National Biotec Group To Collaborate On TLR3 Agonist
Riboxx Pharmaceuticals GmbH and China National Biotec Group have initiated a research collaboration to evaluate a TLR3 agonist from Riboxx.



